Sanofi to acquire Translate Bio
Advances deployment of mRNA technology across vaccines and therapeutics development
Advances deployment of mRNA technology across vaccines and therapeutics development
Deal for 100 million doses with additional 100 million through 2023
PegIFN in COVID19 has several add-on advantages compared to other anti-viral agents
Subscribe To Our Newsletter & Stay Updated